Adding immunotherapy to the usual treatment with cisplatin and radiotherapy after surgery significantly increases disease-free survival in high-risk patients with head and neck cancer.
International study opens door to new standard treatment for head and neck cancer Read More »
The first season of [RE]accions Bellvitge, the new audiovisual series from IDIBELL, premieres with four episodes.
Two IDIBELL researchers, Sara Preciado and Ancor Serrano, will receive funding from the CaixaImpulse program to promote their respective research and innovation projects in health.
A study offers an explanation for the loss of effectiveness of sulfonylureas, one of the most common treatments for type II diabetes.
IDIBELL and the Bellvitge University Hospital have played a key role in the clinical validation of a new blood biomarker discovered and developed in Catalonia which, for the first time, makes it possible to predict the progression from mild cognitive impairment (MCI) to Alzheimer’s dementia. While recently developed international blood biomarkers can confirm the presence
A team from the Cancer Research Centre (University of Salamanca-CSIC), led by Javier Vaquero, and other from IDIBELL, led by Isabel Fabregat, have developed a key study published in the journal Signal transduction and targeted therapy that proposes an innovative strategy to slow the growth of cholangiocarcinoma, a type of liver cancer with a poor prognosis. The work on intrahepatic cholangiocarcinoma identifies a new therapeutic target that allows tumour progression to be blocked in a specific way and with fewer side effects. The research results are a milestone in understanding the mechanisms that regulate tumor growth in cholangiocarcinoma and provide a solid foundation for the development of future more effective and safer therapies.
IDIBELL-ICO researchers propose a new favourable prognostic marker in metastatic uveal melanoma that could serve to clarify the prognostic outlook of patients with metastasis.
A new marker of good prognosis in metastatic uveal melanoma has been identified Read More »
The combination of a low-calorie Mediterranean diet and physical activity can help prevent new cases of type II diabetes.
